Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Masazumi Eriguchi"'
Autor:
Tomoko Ito, Kikuya Sugiura, Aya Hasegawa, Wakana Ouchi, Takayuki Yoshimoto, Izuru Mizoguchi, Toshio Inaba, Katsuyuki Hamada, Masazumi Eriguchi, Yoshiyuki Koyama
Publikováno v:
Pharmaceutics, Vol 13, Iss 1, p 57 (2021)
Tumor-derived extracellular vesicles (EVs), as tumor vaccines, carry tumor-associated antigens (TAAs), and were expected to transfer TAAs to antigen-presenting cells. However, treatment with tumor-derived EVs exhibited no obvious antitumor effect on
Externí odkaz:
https://doaj.org/article/0cd0b7d8775b4d938f809aa0add8bc9f
Autor:
Ryouji Mizumachi, Yuuya Ono, Tomoyuki Hisa, Yoshitaka Furuya, Novriana Dewi, Hiroyuki Takahashi, Jun Nakajima, Tadao Nakashima, Masashi Nagata, Minoru Ono, Yasumasa Nonaka, Toshimitsu Terao, Yasuyuki Morishita, Takashi Fujino, Masashi Yanagawa, Koji Seguchi, Mitsuteru Fujihara, Masazumi Eriguchi, Kazuhiko Arimori, Kazuhiro Kakimi, Takeshi Nagasaki, Takumichi Sugihara, Hironobu Yanagie, Shushi Higashi, Yuuji Murata, Ichiro Ikushima, Takashi Imagawa
Publikováno v:
In Vivo
Background/aim A mixture of anticancer agents and iodized poppy seed oil (IPSO) has been widely used for intra-arterial chemotherapy of hepatocellular carcinoma. However, the anticancer agents can easily separate from IPSO, so the therapeutic potenti
Publikováno v:
Journal of Biomedical Materials Research Part B: Applied Biomaterials. 108:503-512
Films that can form bioadhesive hydrogels on wet biotissues absorbing blood or body fluids are useful for medical devices such as hemostats, adhesion barriers, wound dressings, and drug release devices. We focused on a hydrogen-bonding polymer comple
Autor:
Katsuyuki Hamada, Yoshiyuki Koyama, Aya Hasegawa, Wakana Ouchi, Tomoko Ito, Toshio Inaba, Takayuki Yoshimoto, Masazumi Eriguchi, Izuru Mizoguchi, Kikuya Sugiura
Publikováno v:
Pharmaceutics, Vol 13, Iss 57, p 57 (2021)
Pharmaceutics
Volume 13
Issue 1
Pharmaceutics
Volume 13
Issue 1
Tumor-derived extracellular vesicles (EVs), as tumor vaccines, carry tumor-associated antigens (TAAs), and were expected to transfer TAAs to antigen-presenting cells. However, treatment with tumor-derived EVs exhibited no obvious antitumor effect on
Publikováno v:
MRS Communications. 5:291-295
Poly(acrylic acid) (PAA) and poly(vinylpyrrolidone) (PVP) are both highly safe synthetic polymers approved as pharmaceutical excipients. When their aqueous solutions are mixed, insoluble rigid complex is precipitated. On the other hand, if the dried
Autor:
Aya Hasegawa, Tomoko Ito, Yoshiyuki Koyama, Takahiro Ushigusa, Masazumi Eriguchi, Kikuya Sugiura, Toshio Inaba
Publikováno v:
Biotechnology letters. 38(11)
To examine the potential of exosomes derived from the tumor cells, which had been genetically modified to express a Mycobacterium tuberculosis antigen, as a cancer vaccine aimed at overcoming the weak immunogenicity of tumor antigens. We transfected
Publikováno v:
Journal of Nanomaterials & Molecular Nanotechnology.
Effect of pDNA Complex Particle Size on Gene Expression: Difference between In Vitro and In Vivo Experiments We have developed a novel gene-transfection system comprising very small (70-150 nm) plasmid/polyethyleneimine/hyaluronan (HA) ternary comple
Autor:
Shinichi Takamoto, Hirotaka Sugiyama, Teturo Nishihira, Hiroyuki Takahashi, Yasumasa Nonaka, Aya Ogata, Takayuki Sairennji, T. Hisa, Yoshitaka Furuya, I. Osada, Masazumi Eriguchi, Ayaka Miyazaki, Yosinori Kidani, Hironobu Yanagie
Publikováno v:
Biomedicine & Pharmacotherapy. 63:553-560
It is known that some cancers show platinum complex resistance and that others show platinum complex sensitivity among ovarian cancers. Oxaliplatin (cis-[oxalato[trans-l-1, 2-diamino-cyclohexane] platinum[II]]; l-OHP), an active anti-cancer agent con
Autor:
Hironobu Yanagie, Hiroaki Kumada, Hiroshi Takahashi, K. Ono, T. Nakamura, Hirotaka Sugiyama, Y. Sakurai, Yoshitaka Furuya, Masazumi Eriguchi, Shinichi Takamoto
Publikováno v:
Applied Radiation and Isotopes. 67:S63-S66
Local recurrence breast cancer is one of the most difficult conditions to cure and there is a need for new therapy. If sufficient boron compound can be targeted to the tumor, boron neutron capture therapy (BNCT) can be applied to local recurrent brea
Autor:
Y. Murata, H. Ando, Ryohei Nishimura, Syushi Higashi, Masashi Kimura, Koichi Ogura, Atsuko Shinohara, Hirotaka Sugiyama, Hiroshi Takahashi, Hironobu Yanagie, R. Mizumachi, Ichiro Ikushima, H. Iikura, Naoki Yasuda, Shinichi Takamoto, Shoji Mikado, Masazumi Eriguchi, Yasuyuki Morishita, M. Ishimoto
Publikováno v:
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 605:171-174
It is necessary to accumulate the 10B atoms selectively to the tumor cells for effective Boron Neutron Capture Therapy (BNCT). In order to achieve an accurate measurement of 10B accumulations in the biological samples, we employed a technique of neut